Item 5. Other Information

Rule 10b5-1 Trading Arrangements

Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Global Operations, adopted a pre-arranged trading plan on June 1, 2023, that is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. Ms. Lagano’s plan provides for the sale of up to 10,807 shares of Zoetis common stock between September 1, 2023 and May 20, 2024.

Heidi Chen, Executive Vice President, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics, adopted a pre-arranged trading plan on June 15, 2023, that is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. Ms. Chen’s plan provides for the sale of up to 9,905 shares of Zoetis common stock between September 15, 2023 and September 15, 2025.

41 |